GB201420695D0 - Peptide for HIV detection - Google Patents

Peptide for HIV detection

Info

Publication number
GB201420695D0
GB201420695D0 GBGB1420695.7A GB201420695A GB201420695D0 GB 201420695 D0 GB201420695 D0 GB 201420695D0 GB 201420695 A GB201420695 A GB 201420695A GB 201420695 D0 GB201420695 D0 GB 201420695D0
Authority
GB
United Kingdom
Prior art keywords
peptide
hiv detection
hiv
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB1420695.7A
Other versions
GB2532488B (en
GB2532488A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of the Western Cape
Original Assignee
University of the Western Cape
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of the Western Cape filed Critical University of the Western Cape
Priority to GB1420695.7A priority Critical patent/GB2532488B/en
Publication of GB201420695D0 publication Critical patent/GB201420695D0/en
Priority to AU2015348948A priority patent/AU2015348948A1/en
Priority to PCT/IB2015/058997 priority patent/WO2016079716A1/en
Publication of GB2532488A publication Critical patent/GB2532488A/en
Priority to ZA2017/03730A priority patent/ZA201703730B/en
Application granted granted Critical
Publication of GB2532488B publication Critical patent/GB2532488B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus
    • C07K14/155—Lentiviridae, e.g. human immunodeficiency virus [HIV], visna-maedi virus or equine infectious anaemia virus
    • C07K14/16—HIV-1 ; HIV-2
    • C07K14/161—HIV-1 ; HIV-2 gag-pol, e.g. p55, p24/25, p17/18, p7, p6, p66/68, p51/52, p31/34, p32, p40
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB1420695.7A 2014-11-21 2014-11-21 Use of AMP1 or AMP8 to diagnose HIV infection Active GB2532488B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB1420695.7A GB2532488B (en) 2014-11-21 2014-11-21 Use of AMP1 or AMP8 to diagnose HIV infection
AU2015348948A AU2015348948A1 (en) 2014-11-21 2015-11-20 Peptide for HIV detection
PCT/IB2015/058997 WO2016079716A1 (en) 2014-11-21 2015-11-20 Peptide for hiv detection
ZA2017/03730A ZA201703730B (en) 2014-11-21 2017-05-31 Peptide for hiv detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1420695.7A GB2532488B (en) 2014-11-21 2014-11-21 Use of AMP1 or AMP8 to diagnose HIV infection

Publications (3)

Publication Number Publication Date
GB201420695D0 true GB201420695D0 (en) 2015-01-07
GB2532488A GB2532488A (en) 2016-05-25
GB2532488B GB2532488B (en) 2019-07-31

Family

ID=52292313

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1420695.7A Active GB2532488B (en) 2014-11-21 2014-11-21 Use of AMP1 or AMP8 to diagnose HIV infection

Country Status (4)

Country Link
AU (1) AU2015348948A1 (en)
GB (1) GB2532488B (en)
WO (1) WO2016079716A1 (en)
ZA (1) ZA201703730B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600571A1 (en) * 1986-01-10 1987-08-06 Gruenenthal Gmbh DNA SEQUENCES CODING FOR PROTEINS WITH THE BIOLOGICAL ACTIVITY OF HUSI-TYPI INHIBITORS, GENE-TECHNOLOGICAL METHODS FOR THE PRODUCTION OF THESE PROTEINS AND MEDICINAL PRODUCTS CONTAINING THESE PROTEINS
WO1999064439A2 (en) * 1998-06-12 1999-12-16 Case Western Reserve University Methods for increasing cationic antimicrobial peptides
CN101703758A (en) * 2009-11-03 2010-05-12 暨南大学 Application of silkworm BmcecD1 gene encoding mature peptide in preparation of drugs against colibacillus or pseudomonas aeruginosa
US20110165649A1 (en) * 2010-01-06 2011-07-07 Brett Tyler Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts

Also Published As

Publication number Publication date
ZA201703730B (en) 2018-11-28
AU2015348948A1 (en) 2017-06-01
GB2532488B (en) 2019-07-31
WO2016079716A1 (en) 2016-05-26
GB2532488A (en) 2016-05-25

Similar Documents

Publication Publication Date Title
GB2516131B (en) Proximity detection
GB2533284B (en) Performing object detection
EP3108707A4 (en) Proximity detection
SG11201609562XA (en) Collision detection
GB201418562D0 (en) Peptides
ZA201500063B (en) A detection system
IL251924A0 (en) Malaria detection
GB201513698D0 (en) Object detection
GB201401877D0 (en) Peptides
HK1253316A1 (en) Peptides
GB201411568D0 (en) Detection
TWI562017B (en) Misalignment detection
GB2534372B (en) Cloud Feature Detection
GB201502226D0 (en) AH-7921 detection
GB2528429B (en) Border detection
GB201707731D0 (en) Detection system
SG11201610262TA (en) Object detection system
ZA201703730B (en) Peptide for hiv detection
HK1250260A1 (en) Pharmaceutical detection
GB2532935B (en) Proximity detection system
GB201519558D0 (en) Detection processes
GB201516218D0 (en) Detection system
GB201508766D0 (en) Detection system
GB201403310D0 (en) Polypeptide detection
GB201420645D0 (en) Peptides